Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep248 | Clinical case reports - Pituitary/Adrenal | ECE2016

Kallmann syndrome and ichthiosis. A case of contiguous gene deletion syndrome

Berges-Raso Irene , Gimenez-Palop Olga , Caixas Assumpta , Gabau Elisabeth , Casamitjana Laia , Capel Ismael , Subias David , Rigla Mercedes

Introduction: Kallmann Syndrome (KS) is a genetically heterogeneous disease characterised by hypogonadotrophic hypogonadism with anosmia or hyposmia. It can be associated with X-linked ichthyosis (XLI) in a contiguous gene syndrome related to a Xp22.3 region deletion, which include KAL1 and STS genes.Case report: We report a case of a 32-year-old male with ichthyosis referred for evaluation of high height (2.07 m), overweight (BMI 29.6 kg/m2) ...

ea0063p39 | Adrenal and Neuroendocrine Tumours 1 | ECE2019

A novel CYP11B1 mutation presenting as a classical congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency

Mazarico Isabel , Gimenez-Palop Olga , Albert Lara , Florencia Luchtenberg , Casamitjana Laia , Capel Ismael , Subias David , Cano Albert , Guitart Miriam , Caixas Assumpta , Rigla Mercedes

Background: Congenital adrenal hyperplasia (CAH) is a rare autosomal recessive disorder, of which 21-hydroxylase deficiency (21OHD) is the most frequent form. 11 beta-hydroxylase deficiency (11bOHD) is the second most common type of CAH. This pathology results from inactivating mutations in CYP11B1 gene.Case presentation: We describe a case of a 48-year-old woman with 11bOHD, presented with hypokalemia hypertension, early adrenarche and mild vir...

ea0063p527 | Diabetes, Obesity and Metabolism 2 | ECE2019

Artificial intelligence for the remote evaluation of gestational diabetes using a smartphone application (Sinedie©): Study design.

Albert Lara , Subias David , Casamitjana Laia , Mazarico Isabel , Caballero-Ruiz Estefania , Garcia-Saez Gema , Martin-Redondo Pablo , Hernando Elena , Rigla Mercedes

Background: Gestational diabetes (GD) prevalence is increasing as the obesity epidemic continues. Its management involves hospital visits every 1–2 weeks. In 2016 our team developed a web-based telemedicine platform (SineDie©). This tool operated as a clinical decision support system designed to manage the treatment of patients with GD. SineDie© automatically prescribed diet recommendations and identified the necessity of insulin treatment....

ea0049ep165 | Endocrine tumours and neoplasia | ECE2017

Could alcohol ablation become the standard of care for benign insulinomas?

Mazarico Isabel , Subias David , Junquera Felix , Vilardell Carme , Saigi Ignasi , Cano Albert , Casamitjana Laia , Gimenez-Palop Olga , Albert Lara , Capel Ismael , Caixas Assumpta , Rigla Mercedes

Introduction: Surgical resection is currently considered the standard treatment for symptomatic insulinomas; however, its morbidity is high (>10%) and it is restricted to suitable candidates. In recent years, alternative minimally invasive therapies, such as endoscopic ultrasound (EUS)-guided ethanol ablation (EA), have emerged as new therapeutic options, especially for small lesions or poor surgical candidates. We report two cases of insulinoma ablated with EA.<p clas...

ea0049ep641 | Neuroendocrinology | ECE2017

Comparison of GHRH + arginine vs glucagon test for the evaluation of growth hormone secretion status in a cohort of adults with Prader-Willi syndrome (PWS)

Casamitjana Laia , Olga Gimenez-Palop , Raquel Corripio , Rocio Pareja , Marta Hurtado , Elisabet Gabau , Jesus Cobo , Eugenio Berlanga , Albert Cano , Lara Albert , Mercedes Rigla , Assumpta Caixas

Background: Prader-Willi syndrome (PWS) is a rare genetic disorder evolving morbid obesity and growth hormone deficiency (GHD). Testing GH-IGF1 axis is required before treatment with rhGH in adults with PWS (1). The most common used tests in these patients are GHRH+arginine (GHRH+a) and insulin tolerance test. There are no prospective data for glucagon test (GT) in comparison to GHRH+a in adults with PWS. Mechanism by which GT causes GH release remains unclear, glucagon-induce...

ea0041gp13 | Adrenal (1) | ECE2016

ACTH stimulation test (250 μg): is salivary cortisol an alternative to serum cortisol?

Albert Lara , Gimenez-Palop Olga , Capel Ismael , Miguel Gonzalez-Clemente Jose , Subias David , Sanchez-Delgado Jorge , Profitos Joaquim , Berlanga Eugenio , Casamitjana Laia , Rigla Mercedes

Introduction: Most serum cortisol (SeC) is linked to cortisol binding globulin and albumin. When the synthesis of proteins is reduced or increased, SeC does not reflect the actual free cortisol (FC) (active fraction). Methods for FC analysis are very laborious and expensive, which makes difficult to use them as a routine laboratory tests. Salivary cortisol (SaC) mirrors the FC in serum, being its measurement easier and cheaper. The determination of SaC, instead of tot...

ea0041ep799 | Obesity | ECE2016

16p11.2 Microdeletion and Prader Willi syndrome: similarities and differences

Casamitjana Laia , Caixas Assumpta , Berges Irene-Noelia , Albert Lara , Cano Albert , Capel Ismael , Gimenez-Palop Olga , Gabau Elisabet , Corripio Raquel , Rigla Mercedes

Introduction: Prader Willi syndrome (PWS) is the most common syndromic form of obesity, caused by the absence of expression of the paternally active gens on the long arm of chromosome 15.The 16p11.2 microdeletion has recently been recognized as a syndromic condition appearing to be a predisposing factor for overweight, being the second most common genetic cause of obesity. One possible causative gen- SH2B1- involving leptin and insulin signaling, has been identified, although ...

ea0070aep725 | Pituitary and Neuroendocrinology | ECE2020

One year of growth hormone therapy in spanish adults with prader-willi syndrome (PWS) improves body composition without changes in bone mineral density

Casamitjana Laia , Giménez-Palop Olga , Pareja Rocío , Corripio Raquel , León Josep , Caixàs Assumpta

Introduction: PWS is the most common cause of genetic obesity. These patients have an abnormal body composition with increased amounts of fat mass (FM), reduced lean body mass (LBM) and diminished bone mineral density (BMD), all similar to patients with growth hormone deficiency (GHD).The abnormal body composition has been described due to impairment of the activity of GH-IGF system and to hypogonadism. Studies ongrowth hormone (GH) treatment in PWS adults from other European ...

ea0070ep215 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Decalogue of venipucture process of an experienced nurse in adult patients with prader willi syndrome

Pareja Rocío , Giménez-Palop Olga , Casamitjana Laia , Couto Yolanda , Luengo Marina , Rigla Mercedes , Caixàs Assumpta

Background: Prader-Willi syndrome (PWS) is a genetic neurodevelopmental disorder characterized by marked hyperphagia and morbid obesity, together with hormone deficiencies, abnormal behaviour in relation to food (obsessive thinking, food foraging, stealing, etc.). Veins in patients with PWS are difficult to find due to obesity and probably to generalised hypotonia including venous tone. Since treating a patient with PWS often requires the acquisition of blood samples, an exper...

ea0056p27 | Adrenal cortex (to include Cushing's) | ECE2018

A new ARMC5 mutation responsible for primary bilateral macronodular adrenal hyperplasia

Mazarico Isabel , Subias David , Guitart Miriam , Bella Rosa Maria , Albert Lara , Luchtenberg Florencia , Berges Irene , Capel Ismael , Cano Albert , Casamitjana Laia , Gimenez-Palop Olga , Caixas Assumpta , Rigla Mercedes

Introduction: Primary bilateral macronodular adrenal hyperplasia (PBMAH) is a rare cause (<2 percent) of endogenous Cushing’s syndrome, usually characterized by enlarged adrenal glands containing multiple functioning nonpigmented macronodules. PBMAH was thought to be sporadic, but recently a genetic component has been described. Specifically, inactivating mutations in ARMC5 (Armadillo-repeat containing 5), a suppressor gene, have been found in many familial c...